Avenue Therapeutics Inc

NASDAQ:ATXI  
0.26
+0.01 (+3.21%)
Earnings Announcements

Abeona Therapeutics Inc Says Joseph Vazzano Has Been Appointed Chief Financial Officer

Published: 03/31/2022 11:42 GMT
Avenue Therapeutics Inc (ATXI) - Abeona Therapeutics Inc Says Joseph Vazzano Has Been Appointed Chief Financial Officer.
Abeona Therapeutics Inc - Qtrly Basic and Diluted Loss per Common Share $0.45.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.